DWM
UTHR icon

Dogwood Wealth Management’s United Therapeutics UTHR Stock Holding History

Dogwood Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79K Buy
7
+3
+75% +$1.69K ﹤0.01% 558
2026
Q1 		$2.37K Buy
+4
New +$1.99K ﹤0.01% 613

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dogwood Wealth Management's UTHR Position: Q2 2026 in Review

Dogwood Wealth Management increased its United Therapeutics (UTHR) stake by 75% in Q2 2026, buying an estimated $1.69K and bringing the position to 7 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Dogwood Wealth Management first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Dogwood Wealth Management held 7 shares of United Therapeutics worth $3.79K as of Q2 2026.
  • Dogwood Wealth Management bought 3 United Therapeutics shares in Q2 2026, an estimated $1.69K.
  • United Therapeutics made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #558 holding.
  • Dogwood Wealth Management first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.